Should You Buy JPMorgan Chase & Co (JPM) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/29
Not a good buy right now for an impatient investor. JPM is sitting right on the pivot (~305.8) with neutral momentum (RSI ~52) and still-negative MACD, meaning upside exists but isn’t supported by a fresh technical breakout or a proprietary buy signal. With insiders aggressively selling recently and earnings/EPS down YoY in the latest quarter, the risk/reward for buying immediately looks only متوسط (balanced) rather than compelling. I would wait for either a pullback toward support (~297–293) or a clean push above ~314 before calling it a high-conviction buy.
Technical Analysis
Price/levels: Last close 305.51, essentially at the pivot (305.787). Near-term upside targets are R1 313.694 then R2 318.579; downside supports are S1 297.879 then S2 292.994.
Trend/momentum: MACD histogram is negative (-1.484) but contracting, which suggests bearish momentum is fading rather than accelerating. RSI(6) at 51.656 is neutral (no oversold bounce signal, no overbought breakout signal).
Moving averages: Converging moving averages typically signal consolidation and an upcoming directional move, but direction is not confirmed yet.
Pattern-based short-term odds: Similar-pattern stats imply a mild positive bias in the next day/week (+1.19% next day; +1.05% next week), but a softer next-month expectation (-1.76%), consistent with ‘range-to-slightly-down’ without a strong catalyst.
Intellectia Proprietary Trading Signals:
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
Recent trend: Price targets have generally moved up across the Street (notably TD Cowen 375→400 and Barclays 342→391), suggesting improving forward assumptions (NII, fees, buybacks). However, ratings are mixed: bullish voices (TD Cowen Buy, Barclays Overweight, KBW Outperform) are offset by neutral stances (Truist Hold, HSBC Hold, Morgan Stanley Equal Weight) and a downgrade (Wolfe to Peer Perform).
Wall Street pros/cons view: Pros emphasize JPM’s ‘best-in-class’ franchise, durable tailwinds into 2026, and operating leverage/capital return potential. Cons focus on valuation/expectations, expense guidance sensitivity, and the idea that upside may be more incremental unless a clear catalyst (rates/IB surge) materializes.
Wall Street analysts forecast JPM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JPM is 341.38 USD with a low forecast of 260 USD and a high forecast of 400 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast JPM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JPM is 341.38 USD with a low forecast of 260 USD and a high forecast of 400 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 300.770
Current: 300.770
